Evidence map›Paper›PMID 22096617›Full record

ArticleEuropean journal of microbiology & immunology2011

CONTINUOUS REPOPULATION OF LYMPHOCYTE SUBSETS IN TRANSPLANTED MYCOBACTERIAL GRANULOMAS.

H A Schreiber, J S Harding, C J Altamirano, O Hunt, P D Hulseberg, Zs Fabry, M Sandor

Open access · greenAbstract read
In one paragraph

Article in European journal of microbiology & immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Pathological and protective roles of dendritic cells inFrontiers in cellular and infection microbiology · 2022
    Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

H A SchreiberDepartment of Pathology and Laboratory Medicine, University of Wisconsin, School of Medicine and Public Health, Madison, WI 53706, USA.
J S Harding
C J Altamirano
O Hunt
P D Hulseberg
Zs Fabry
M Sandor
University of Wisconsin–Madison · US

Funding

T CELLS IN GRANULOMATOUS IMMUNE RESPONSESR01AI048087 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI SANDOR, MATYAS · 2000 to 2011
$2.6M
Traffic from chronic mycobacterium induced granulomasR21AI072638 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI SANDOR, MATYAS · 2008 to 2009
$401k
NIAID NIH HHS R01 AI048087NIAID NIH HHS R21 AI072638
6 · The paper itself

Abstract

Granulomas are the interface between host and mycobacteria, and are crucial for the surivival of both species. While macrophages are the main cellular component of these lesions, different lymphocyte subpopulations within the lesions also play important roles. Lymphocytes are continuously recruited into these inflammatory lesions via local vessels to replace cells that are either dying or leaving; however, their rate of replacement is not known. Using a model of granuloma transplantation and fluorescently labeled cellular compartments we report that, depending on the subpopulation, 10-80%, of cells in the granuloma are replaced within one week after transplantation. CD4(+) T cells specific for Mycobacterium antigen entered transplanted granulomas at a higher frequency than Foxp3(+) CD4(+) T cells by one week. Interestingly, a small number of T lymphocytes migrated out of the granuloma to secondary lymphoid organs. The mechanisms that define the differences in recruitment and efflux behind each subpopulation requires further studies. Ultimately, a better understanding of lymphoid traffic may provide new ways to modulate, regulate, and treat granulomatous diseases.

Identifiers

PMID22096617
PMCPMC3215294
OpenAlexW2011718118

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.